Skip to main content
Log in

The effects of acute ethanol intake on isoniazid pharmacokinetics

  • Short Communication
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

Aim

To assess effects of acute ethanol intake on the pharmacokinetics of isoniazid in healthy male volunteers.

Methods

Sixteen healthy male, drug-free subjects were studied. Each received in the fasting state, on two occasions separated by at least 1 week, isoniazid (200 mg orally). On one occasion (assigned randomly), subjects received ethanol 0.73 g/kg, 1 h before isoniazid, followed by 0.11 g/kg ethanol orally every hour thereafter for 7 h. Plasma isoniazid and acetylisoniazid concentrations were measured by means of high-performance liquid chromatography. Blood ethanol concentrations were measured hourly by breath analysis. Plasma concentrations of isoniazid and acetylisoniazid were analysed using TOPFIT software.

Results

Peak concentrations of isoniazid were reached within 90 min, in both the ethanol-treated and control groups. The ethanol dosage regimen used resulted in peak blood ethanol concentrations between 78 mg/l and 103 mg/l. There was no significant difference in area under the curve, half-life of elimination or the ratio of acetylisoniazid to isoniazid (AcINH/INH) in the sample withdrawn 3 h after isoniazid dose. Acetylator phenotype for patients was the same in both phases, whether assessed by half-life of isoniazid or the AcINH/INH ratio at 3 h.

Conclusions

Acute ethanol intake at this dose is unlikely to affect results of acetylation studies in which isoniazid is used as a substrate, whether the half-life of isoniazid or the AcINH /INH ratio at 3 h is used to phenotype patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Price Evans DA (1992) N-acetyltransferase. In: Kalow W (ed) Pharmacogenetics of drug metabolism. Pergamon Press, New York

    Google Scholar 

  2. Drayer DE, Reidenberg MM (1977) Clinical consequences of polymorphic acetylation of basic drugs. Clin Pharmacol Ther 22(3):221–228

    Google Scholar 

  3. Olsen H, Morland J (1983) Ethanol interaction with drug acetylation in vivo and in vitro. Pharmacol Biochem Behav 18(1):295–300

    Article  CAS  Google Scholar 

  4. Olsen H, Morland J (1982) Ethanol-induced increase in procainamide acetylation in man. Br J Clin Pharmacol 13:203–208

    CAS  PubMed  Google Scholar 

  5. Olsen H, Morland J (1978) Ethanol-induced increase in drug acetylation in man and isolated rat liver cells. BMJ 2:1260–1262

    CAS  PubMed  Google Scholar 

  6. Weber WW, Hein DW (1979) Clinical pharmacokinetics of isoniazid. Clin Pharmacokinet 4:401–422

    CAS  PubMed  Google Scholar 

  7. Ahmad RA, Rogers HJ, Vandenburg M, Wright P (1981) Effects of concurrent administration of other substrates of N-acetyltransferase on dapsone acetylation. Br J Clin Pharmacol 12:83–86

    CAS  PubMed  Google Scholar 

  8. Clark DW (1985) Genetically determined variability in acetylation and oxidation. Therapeutic implications. Drugs 29:342–375

    CAS  PubMed  Google Scholar 

  9. Notarianni LJ, Dobrocky P, Godlewski G, Jones RW, Bennett PN (1996) Caffeine as a metabolic probe: NAT2 phenotyping. Br J Clin Pharmacol 41:169–173

    CAS  PubMed  Google Scholar 

  10. Hutchings AD, Routledge PA (1996) A single sample saliva test to determine acetylator phenotype. Br J Clin Pharmacol 42:635–637

    CAS  PubMed  Google Scholar 

  11. Hutchings AD, Monie RD, Spragg BP, Routledge PA (1988) Saliva and plasma concentrations of isoniazid and acetylisoniazid in man. Br J Clin Pharmacol 25:585–589

    CAS  PubMed  Google Scholar 

  12. Hutchings A, Routledge PA (1986) A simple method for determining acetylator phenotype using isoniazid. Br J Clin Pharmacol 22:343–345

    CAS  PubMed  Google Scholar 

  13. Hutchings A, Monie RD, Spragg B, Routledge PA (1983) A method to prevent the loss of isoniazid and acetylisoniazid in human plasma. Br J Clin Pharmacol 15:263–266

    CAS  PubMed  Google Scholar 

  14. Hutchings A, Monie RD, Spragg B, Routledge PA (1983) High-performance liquid chromatographic analysis of isoniazid and acetylisoniazid in biological fluids. J Chromatogr 277:385–390

    Article  CAS  PubMed  Google Scholar 

  15. Weber WW (1987) The acetylator genes and drug response. Oxford University Press, New York

    Google Scholar 

  16. Vas A, Gachalyi B, Kaldor A (1990) Pantothenic acid, acute ethanol consumption and sulphadimidine acetylation. Int J Clin Pharmacol Ther Toxicol 28:111–114

    CAS  PubMed  Google Scholar 

  17. Estler CJ (1979) Effect of ethanol on levels of isoniazid, sulfanilamide and sulfapyridin in mouse blood. Experientia 35:368–369

    CAS  PubMed  Google Scholar 

  18. Lester D (1964) The acetylation of isoniazid in alcoholics. Q J Stud Alcohol 25:541–543

    CAS  PubMed  Google Scholar 

  19. Hutchings A, Monie RD, Spragg B, Routledge PA (1984) Acetylator phenotyping: the effect of ethanol on the dapsone test. Br J Clin Pharmacol 18:98–100

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R.G. Dattani.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dattani, R., Harry, F., Hutchings, A. et al. The effects of acute ethanol intake on isoniazid pharmacokinetics. Eur J Clin Pharmacol 60, 679–682 (2004). https://doi.org/10.1007/s00228-004-0828-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-004-0828-y

Keywords

Navigation